Hypogonadotropic hypogonadism: gonadotropin-releasing hormone therapy.
Whitcomb
R W
RW
Parke-Davis Pharmaceutical Research, Ann Arbor, Michigan.
Crowley
W F
WF
D000293:Adolescent; D000328:Adult; D002648:Child; D007987:Gonadotropin-Releasing Hormone / Q000009:adverse effects / Q000172:deficiency* / Q000627:therapeutic use*; D006801:Humans; D007006:Hypogonadism / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology*; D017436:Kallmann Syndrome / Q000188:drug therapy / Q000235:genetics / Q000503:physiopathology; D007986:Luteinizing Hormone / Q000097:blood / Q000378:metabolism; D008297:Male; D013091:Spermatogenesis; D013739:Testosterone / Q000097:blood
D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; D007986:Luteinizing Hormone